Tech Company Financing Transactions
Bacchus Vascular Funding Round
Warburg Pincus, De Novo Ventures and The Vertical Group participated in a $25 million Series D funding round for Bacchus Vascular. The round closed on 7/8/2003.
Transaction Overview
Company Name
Announced On
7/8/2003
Transaction Type
Venture Equity
Amount
$25,000,000
Round
Series D
Investors
Proceeds Purpose
The proceeds from the Series D financing will be used for new product development, commercialization and marketing of the company's current product lines including the Trellis Reserve drug infusion catheter and the Solera mechanical thrombectomy device.
Company Information
Company Status
Acquired or Merged
Industry
Medical Devices & Instruments
Mailing Address
3110 Coronado Dr.
Santa Clara, CA 95054
USA
Santa Clara, CA 95054
USA
Phone
Website
Email Address
Overview
Bacchus Vascular is an emerging medical device company focused on the discovery and development of innovative treatments for cardiovascular and peripheral occlusive vascular disease.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Scott Cramer
Chief Financial Officer
Mike Gandy
VP - Bus. Development
Bob McRae
VP - Marketing
Dennis Rosenberg
VP - Operations
Ali Shirazi
VP - Sales
Eric Heil
Browse more venture capital transactions:
Prev: 7/7/2003: Magnolia Broadband venture capital transaction
Next: 7/8/2003: Cast Iron Systems venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on funding rounds that are announced publicly. VC transactions reported here are sourced from company press releases and news coverage. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs